DIETHYLPROPION HYDROCHLORIDE

DIETHYLPROPION HYDROCHLORIDE was reported 129 times

DIETHYLPROPION HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERPHENYLALANINAEMIA 1 0.0667
1 METHYLENETETRAHYDROFOLATE REDUCTASE GENE MUTATION 1 0.0208
2 BLOOD CORTICOTROPHIN ABNORMAL 1 0.0104
3 POST PROCEDURAL CONSTIPATION 1 0.0068
4 GINGIVAL ATROPHY 1 0.0051
5 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
6 CYSTITIS BACTERIAL 1 0.0030
7 TRACHEOMALACIA 1 0.0025
8 SINONASAL OBSTRUCTION 1 0.0025
9 SPINAL CORD INFARCTION 1 0.0023
10 POST THROMBOTIC SYNDROME 1 0.0022
11 SCIATIC NERVE NEUROPATHY 1 0.0019
12 BODY TINEA 1 0.0018
13 PERNICIOUS ANAEMIA 1 0.0016
14 BLOOD CORTISOL DECREASED 1 0.0016
15 BONE OPERATION 1 0.0015
16 BRONCHITIS BACTERIAL 1 0.0013
17 PELVIC MASS 1 0.0012
18 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
19 SMALL FOR DATES BABY 6 0.0012
20 HEPATITIS A 1 0.0012
21 ALLERGIC SINUSITIS 1 0.0012
22 ENDOCRINE OPHTHALMOPATHY 1 0.0012
23 SELECTIVE EATING DISORDER 1 0.0011
24 WRIST SURGERY 1 0.0011
25 RHEUMATOID LUNG 1 0.0010
26 GALLBLADDER INJURY 2 0.0010
27 ARTHRODESIS 1 0.0010
28 DUODENITIS 3 0.0010
29 TUMOUR NECROSIS 1 0.0009
30 ADMINISTRATION SITE PAIN 1 0.0009
31 EMBOLISM ARTERIAL 1 0.0008
32 INFUSION SITE IRRITATION 1 0.0008
33 ISCHAEMIC HEPATITIS 1 0.0007
34 HYPOTONIA NEONATAL 1 0.0006
35 HYPOGLYCAEMIA NEONATAL 1 0.0006
36 RESPIRATORY DISORDER NEONATAL 1 0.0006
37 TONSILLECTOMY 1 0.0006
38 CEREBELLAR INFARCTION 1 0.0006
39 BILIARY DYSKINESIA 1 0.0006
40 INFUSION SITE DISCHARGE 1 0.0006
41 FEAR OF DISEASE 1 0.0006
42 JOINT ARTHROPLASTY 1 0.0006
43 PLASMACYTOMA 1 0.0005
44 NARCOLEPSY 1 0.0005
45 NEUROGENIC BLADDER 1 0.0005
46 FACIAL PALSY 1 0.0005
47 TEMPERATURE REGULATION DISORDER 1 0.0004
48 TONGUE BLISTERING 1 0.0004
49 CHOLECYSTITIS CHRONIC 3 0.0004
50 LARGE INTESTINAL OBSTRUCTION 1 0.0004
51 DENGUE FEVER 1 0.0004
52 NEPHROGENIC ANAEMIA 2 0.0004
53 BRONCHITIS CHRONIC 1 0.0004
54 HAEMATOLOGICAL INFECTION 1 0.0004
55 DEVICE INFUSION ISSUE 1 0.0004
56 HYPERPARATHYROIDISM SECONDARY 1 0.0004
57 VITAMIN B12 DECREASED 1 0.0003
58 BILIARY COLIC 1 0.0003
59 NECK INJURY 1 0.0003
60 FAMILY STRESS 1 0.0003
61 HEPATIC NEOPLASM 1 0.0003
62 DEAFNESS NEUROSENSORY 1 0.0003
63 INFUSION SITE HAEMORRHAGE 1 0.0003
64 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
65 TONGUE ULCERATION 1 0.0003
66 DEPRESSION SUICIDAL 1 0.0003
67 END STAGE RENAL DISEASE 5 0.0003
68 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
69 SENSATION OF HEAVINESS 1 0.0003
70 RESPIRATORY ACIDOSIS 1 0.0003
71 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
72 CONGESTIVE CARDIOMYOPATHY 1 0.0002
73 POOR PERIPHERAL CIRCULATION 1 0.0002
74 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
75 IMPAIRED GASTRIC EMPTYING 3 0.0002
76 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
77 NEPHROPATHY 2 0.0002
78 UMBILICAL HERNIA 1 0.0002
79 IMPAIRED QUALITY OF LIFE 3 0.0002
80 FOOT OPERATION 1 0.0002
81 DIABETIC NEUROPATHY 1 0.0002
82 ABDOMINAL TENDERNESS 1 0.0002
83 CORONARY ARTERY STENOSIS 1 0.0002
84 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
85 CHRONIC KIDNEY DISEASE 15 0.0002
86 PETIT MAL EPILEPSY 1 0.0002
87 PHLEBITIS 1 0.0002
88 ENDOCARDITIS 1 0.0002
89 VARICOSE VEIN 1 0.0002
90 PHARYNGITIS STREPTOCOCCAL 2 0.0002
91 URINE ODOUR ABNORMAL 1 0.0002
92 DRUG ABUSER 1 0.0002
93 MENISCUS INJURY 1 0.0002
94 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
95 PRE-EXISTING CONDITION IMPROVED 1 0.0002
96 INFUSION SITE SWELLING 1 0.0002
97 SLEEP APNOEA SYNDROME 3 0.0002
98 CARDIAC FAILURE ACUTE 1 0.0001
99 PRODUCT PHYSICAL ISSUE 3 0.0001
100 POSTOPERATIVE WOUND INFECTION 1 0.0001
101 PRODUCT TASTE ABNORMAL 2 0.0001
102 CARPAL TUNNEL SYNDROME 2 0.0001
103 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
104 UTERINE LEIOMYOMA 1 0.0001
105 SENSITIVE SKIN 1 0.0001
106 FOOD ALLERGY 1 0.0001
107 CONCUSSION 1 0.0001
108 ESCHERICHIA INFECTION 1 0.0001
109 ACUTE CORONARY SYNDROME 1 0.0001
110 INFUSION SITE ERYTHEMA 1 0.0001
111 PSYCHOLOGICAL TRAUMA 1 0.0001
112 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
113 GRIP STRENGTH DECREASED 1 0.0001
114 GALLBLADDER DISORDER 2 0.0001
115 LOSS OF LIBIDO 1 0.0001
116 OPTIC NEURITIS 1 0.0001
117 PNEUMONIA BACTERIAL 1 0.0001
118 BRAIN NEOPLASM 1 0.0001
119 RETINAL DETACHMENT 1 0.0001
120 NERVE COMPRESSION 1 0.0001
121 APPENDICITIS 1 0.0001
122 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
123 SINUS BRADYCARDIA 1 0.0001
124 COELIAC DISEASE 1 0.0001
125 INABILITY TO AFFORD MEDICATION 1 0.0001
126 BRAIN INJURY 1 0.0001
127 VENTRICULAR EXTRASYSTOLES 1 0.0001
128 RENAL FAILURE 12 0.0001
129 DERMATITIS CONTACT 1 0.0001
130 CHOLECYSTECTOMY 1 0.0001
131 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
132 INJURY 6 0.0001
133 CHOLECYSTITIS 1 0.0001
134 HYPERLIPIDAEMIA 1 0.0001
135 NOCTURIA 1 0.0001
136 SMALL INTESTINAL OBSTRUCTION 1 0.0001
137 GENERALISED OEDEMA 1 0.0001
138 ILEUS 1 0.0001
139 INJECTION SITE DISCOLOURATION 1 0.0001
140 SECRETION DISCHARGE 1 0.0001
141 INJECTION SITE IRRITATION 1 0.0001
142 INFUSION SITE PAIN 1 0.0001
143 HIATUS HERNIA 1 0.0001
144 PLATELET COUNT INCREASED 1 0.0001
145 ANHEDONIA 2 0.0001
146 ANKYLOSING SPONDYLITIS 1 0.0001
147 EAR INFECTION 2 0.0001
148 QUALITY OF LIFE DECREASED 1 0.0001
149 AKATHISIA 1 0.0001
150 ACUTE HEPATIC FAILURE 1 0.0001
151 SEASONAL ALLERGY 1 0.0001
152 INTENTIONAL DOSE OMISSION 2 0.0001
153 PARAESTHESIA ORAL 1 0.0001
154 ANOSMIA 1 0.0001
155 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
156 HYPOAESTHESIA ORAL 1 0.0001
157 ECONOMIC PROBLEM 1 0.0001
158 BONE DENSITY DECREASED 2 0.0001
159 CYSTITIS 2 0.0001
160 OBESITY 1 0.0001
161 BLOOD POTASSIUM INCREASED 1 0.0001
162 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
163 BACK DISORDER 1 0.0001
164 CHOLELITHIASIS 2 0.0001
165 DRY EYE 3 0.0001
166 CANDIDA INFECTION 1 0.0001
167 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
168 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
169 ORTHOSTATIC HYPOTENSION 1 0.0001
170 LOCAL SWELLING 1 0.0001
171 THIRST 1 0.0001
172 GASTROENTERITIS VIRAL 1 0.0001
173 BLOOD SODIUM DECREASED 1 0.0001
174 ACUTE KIDNEY INJURY 8 0.0001
175 POST PROCEDURAL COMPLICATION 1 0.0001
176 ACUTE RESPIRATORY FAILURE 1 0.0001
177 DYSTONIA 1 0.0001
178 NASAL CONGESTION 3 0.0001
179 KIDNEY INFECTION 1 0.0001
180 BLOOD PRESSURE ABNORMAL 1 0.0001
181 PREGNANCY 1 0.0000
182 FULL BLOOD COUNT DECREASED 1 0.0000
183 EMOTIONAL DISTRESS 6 0.0000
184 FEEDING DISORDER 1 0.0000
185 DYSKINESIA 2 0.0000
186 BODY TEMPERATURE INCREASED 1 0.0000
187 SINUSITIS 5 0.0000
188 RETCHING 1 0.0000
189 SKIN CANCER 1 0.0000
190 RHINORRHOEA 3 0.0000
191 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
192 HEPATOTOXICITY 1 0.0000
193 INJECTION SITE PRURITUS 3 0.0000
194 ORAL PAIN 1 0.0000
195 RASH PAPULAR 1 0.0000
196 CARDIAC DISORDER 4 0.0000
197 DIABETIC KETOACIDOSIS 1 0.0000
198 EXTRAPYRAMIDAL DISORDER 1 0.0000
199 ERECTILE DYSFUNCTION 1 0.0000
200 SKIN ULCER 1 0.0000
201 RESPIRATORY TRACT INFECTION 1 0.0000
202 NERVOUSNESS 2 0.0000
203 GASTRITIS 1 0.0000
204 PANCREATITIS 2 0.0000
205 CARDIAC FAILURE CONGESTIVE 3 0.0000
206 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
207 PAIN OF SKIN 1 0.0000
208 DIVERTICULITIS 1 0.0000
209 WOUND 1 0.0000
210 TARDIVE DYSKINESIA 1 0.0000
211 ASTHMA 4 0.0000
212 ANXIETY 10 0.0000
213 ANGINA PECTORIS 1 0.0000
214 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
215 NEEDLE ISSUE 1 0.0000
216 WHEEZING 2 0.0000
217 RENAL INJURY 1 0.0000
218 HYPOAESTHESIA 5 0.0000
219 PREMATURE BABY 1 0.0000
220 INJECTION SITE RASH 1 0.0000
221 EMOTIONAL DISORDER 1 0.0000
222 HEAD INJURY 1 0.0000
223 PULMONARY EMBOLISM 3 0.0000
224 HYPOTHYROIDISM 1 0.0000
225 ATRIAL FIBRILLATION 3 0.0000
226 INFUSION RELATED REACTION 2 0.0000
227 DEHYDRATION 4 0.0000
228 SKIN DISORDER 1 0.0000
229 TYPE 2 DIABETES MELLITUS 1 0.0000
230 BRONCHITIS 2 0.0000
231 INFLUENZA 3 0.0000
232 INTESTINAL OBSTRUCTION 1 0.0000
233 DEPRESSION 6 0.0000
234 INJECTION SITE SWELLING 2 0.0000
235 ALOPECIA 5 0.0000
236 PARAESTHESIA 4 0.0000
237 WEIGHT DECREASED 7 0.0000
238 EXTRA DOSE ADMINISTERED 1 0.0000
239 BLINDNESS 1 0.0000
240 TREATMENT FAILURE 2 0.0000
241 CARDIO-RESPIRATORY ARREST 1 0.0000
242 ROAD TRAFFIC ACCIDENT 1 0.0000
243 RENAL IMPAIRMENT 2 0.0000
244 OSTEOARTHRITIS 1 0.0000
245 URINARY TRACT INFECTION 4 0.0000
246 HYPERHIDROSIS 3 0.0000
247 DEVICE DISLOCATION 1 0.0000
248 MENTAL DISORDER 1 0.0000
249 MYOCARDIAL INFARCTION 4 0.0000
250 PULMONARY OEDEMA 1 0.0000
251 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
252 THERAPY NON-RESPONDER 1 0.0000
253 SKIN IRRITATION 1 0.0000
254 SKIN DISCOLOURATION 1 0.0000
255 NASOPHARYNGITIS 4 0.0000
256 HYPOKALAEMIA 1 0.0000
257 BLOOD CHOLESTEROL INCREASED 1 0.0000
258 COGNITIVE DISORDER 1 0.0000
259 PAIN 13 0.0000
260 NEUROPATHY PERIPHERAL 2 0.0000
261 PRODUCTIVE COUGH 1 0.0000
262 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
263 SOMNOLENCE 4 0.0000
264 CELLULITIS 1 0.0000
265 HAEMOGLOBIN DECREASED 2 0.0000
266 ECZEMA 1 0.0000
267 DERMATITIS ATOPIC 1 0.0000
268 DRUG INTERACTION 3 0.0000
269 DISTURBANCE IN ATTENTION 1 0.0000
270 RASH PRURITIC 1 0.0000
271 OEDEMA 1 0.0000
272 TREATMENT NONCOMPLIANCE 1 0.0000
273 HAEMATOCHEZIA 1 0.0000
274 SEPSIS 2 0.0000
275 PANCYTOPENIA 1 0.0000
276 NECK PAIN 1 0.0000
277 COUGH 5 0.0000
278 LETHARGY 1 0.0000
279 EYE IRRITATION 1 0.0000
280 COVID-19 3 0.0000
281 DYSPHONIA 1 0.0000
282 SURGERY 1 0.0000
283 VOMITING 8 0.0000
284 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
285 IRRITABILITY 1 0.0000
286 VERTIGO 1 0.0000
287 DISCOMFORT 1 0.0000
288 MUSCLE SPASMS 3 0.0000
289 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
290 CHEST PAIN 3 0.0000
291 ANAEMIA 3 0.0000
292 DEEP VEIN THROMBOSIS 1 0.0000
293 BLOOD CREATININE INCREASED 1 0.0000
294 DRY SKIN 2 0.0000
295 HEPATIC ENZYME INCREASED 1 0.0000
296 ERYTHEMA 3 0.0000
297 ABDOMINAL PAIN UPPER 3 0.0000
298 MEMORY IMPAIRMENT 2 0.0000
299 BURNING SENSATION 1 0.0000
300 DIZZINESS 7 0.0000
301 INFECTION 2 0.0000
302 CONSTIPATION 3 0.0000
303 HOT FLUSH 1 0.0000
304 ACNE 1 0.0000
305 DIABETES MELLITUS 1 0.0000
306 BLOOD PRESSURE INCREASED 2 0.0000
307 DECREASED APPETITE 3 0.0000
308 BACK PAIN 3 0.0000
309 CARDIAC FAILURE 1 0.0000
310 THROMBOSIS 1 0.0000
311 DRY MOUTH 1 0.0000
312 TREMOR 2 0.0000
313 FALL 4 0.0000
314 COMPLETED SUICIDE 1 0.0000
315 URTICARIA 2 0.0000
316 ABDOMINAL DISCOMFORT 2 0.0000
317 INTENTIONAL PRODUCT MISUSE 1 0.0000
318 MUSCULOSKELETAL STIFFNESS 1 0.0000
319 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
320 GASTROINTESTINAL DISORDER 1 0.0000
321 OROPHARYNGEAL PAIN 1 0.0000
322 HYPERSENSITIVITY 2 0.0000
323 SWELLING 1 0.0000
324 DYSPNOEA 6 0.0000
325 DYSPHAGIA 1 0.0000
326 CONTUSION 1 0.0000
327 DYSPEPSIA 1 0.0000
328 DRUG INEFFECTIVE 13 0.0000
329 INJECTION SITE PAIN 3 0.0000
330 ILLNESS 1 0.0000
331 ABDOMINAL DISTENSION 1 0.0000
332 HAEMORRHAGE 1 0.0000
333 DIARRHOEA 6 0.0000
334 OVERDOSE 2 0.0000
335 PNEUMONIA 3 0.0000
336 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
337 WEIGHT INCREASED 2 0.0000
338 NAUSEA 7 0.0000
339 RHEUMATOID ARTHRITIS 1 0.0000
340 MUSCULAR WEAKNESS 1 0.0000
341 INCORRECT DOSE ADMINISTERED 2 0.0000
342 SEIZURE 1 0.0000
343 ABDOMINAL PAIN 2 0.0000
344 PALPITATIONS 1 0.0000
345 CHILLS 1 0.0000
346 JOINT SWELLING 1 0.0000
347 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
348 INJECTION SITE ERYTHEMA 1 0.0000
349 LOSS OF CONSCIOUSNESS 1 0.0000
350 FATIGUE 6 0.0000
351 PSORIASIS 1 0.0000
352 INSOMNIA 2 0.0000
353 VISION BLURRED 1 0.0000
354 ARTHRALGIA 3 0.0000
355 RASH 3 0.0000
356 MALAISE 3 0.0000
357 PRODUCT DOSE OMISSION ISSUE 2 0.0000
358 PAIN IN EXTREMITY 2 0.0000
359 HOSPITALISATION 1 0.0000
360 PERIPHERAL SWELLING 1 0.0000
361 DRUG DEPENDENCE 1 0.0000
362 MYALGIA 1 0.0000
363 PRODUCT USE ISSUE 1 0.0000
364 ASTHENIA 2 0.0000
365 BLOOD GLUCOSE INCREASED 1 0.0000
366 GAIT DISTURBANCE 1 0.0000
367 HEADACHE 3 0.0000
368 HYPERTENSION 1 0.0000
369 FEELING ABNORMAL 1 0.0000
370 DEATH 3 0.0000
371 OFF LABEL USE 3 0.0000
372 CONDITION AGGRAVATED 1 0.0000
373 PYREXIA 1 0.0000
374 PRURITUS 1 0.0000